Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E. Ware, Robert J. Adams, Alex George et al.|The Lancet|2015Cited by 518
Impact of a transition program with navigator on loss to follow‐up, medication adherence, and appointment attendance in hemoglobinopathiesBrooke Allemang, Kevin H.M. Kuo, Kate Allan et al.|Pediatric Blood & Cancer|2019Cited by 58
Comprehensive Structured Transition Program With Dedicated Transition Navigator Reduced Lost to Follow-Up and Improved Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease and ThalassemiaBrooke Allemang, Kevin H.M. Kuo, Kate Allan et al.|Journal of Adolescent Health|2017Cited by 6
Comprehensive Structured Transition Program with Dedicated Transition Navigator Reduced Lost to Follow-up and Improved Medication Adherence in Sickle Cell Disease and Thalassemia Adolescents and Young AdultsBrooke Allemang, Kevin H.M. Kuo, Kate Allan et al.|Blood|2016Cited by 4